Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Haschke

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Clinical Pharmacokinetics|May 18, 2013
Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjectsManuel Haschke, Manfred Schuster, Marko Poglitsch, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 22, 2009
Comparison of the dissolution and pharmacokinetic profiles of two galenical formulations of the endothelin receptor antagonist macitentanOliver Kummer, Manuel Haschke, Felix Hammann, et al.
Therapeutic Drug Monitoring|January 29, 2008
Pharmacokinetics and pharmacodynamics of sildenafil in a patient treated with human immunodeficiency virus protease inhibitorsYvonne Zysset Aschmann, Oliver Kummer, André Linka, et al.
Clinical Pharmacology and Therapeutics|December 18, 2020
Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2Fabio Bachmann, Urs Duthaler, Henriette E Meyer Zu Schwabedissen, et al.
Exploratory Research in Clinical and Social Pharmacy|May 27, 2026
Deprescribing of proton pump inhibitors in internal medicine in-patients: A retrospective observational studyChristina Kotoula, Leonie Daria Schreck, Arani Anandarathakrishnan, et al.
International Journal of Antimicrobial Agents|July 25, 2013
Activity of dalbavancin, alone and in combination with rifampicin, against meticillin-resistant Staphylococcus aureus in a foreign-body infection modelDaniela Baldoni, Ulrika Furustrand Tafin, Sandrine Aeppli, et al.
British Journal of Clinical Pharmacology|September 22, 2020
Effects of Hypericum perforatum (St John's wort) on the pharmacokinetics and pharmacodynamics of rivaroxaban in humansIrene Scholz, Evangelia Liakoni, Felix Hammann, et al.
Plos One|June 7, 2014
A study of the relationship between serum bile acids and propranolol pharmacokinetics and pharmacodynamics in patients with liver cirrhosis and in healthy controlsAnne B Taegtmeyer, Manuel Haschke, Lydia Tchambaz, et al.
Biochemical Pharmacology|January 18, 2019
Non-immunological toxicological mechanisms of metamizole-associated neutropenia in HL60 cellsDeborah Rudin, Angelo Lanzilotto, Fabio Bachmann, et al.
British Journal of Clinical Pharmacology|October 29, 2019
Pharmacokinetics and phenotyping properties of the Basel phenotyping cocktail combination capsule in healthy male adultsClaudia Suenderhauf, Benjamin Berger, Maxim Puchkov, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Clinical Pharmacokinetics|May 18, 2013
Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjectsManuel Haschke, Manfred Schuster, Marko Poglitsch, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 22, 2009
Comparison of the dissolution and pharmacokinetic profiles of two galenical formulations of the endothelin receptor antagonist macitentanOliver Kummer, Manuel Haschke, Felix Hammann, et al.
Therapeutic Drug Monitoring|January 29, 2008
Pharmacokinetics and pharmacodynamics of sildenafil in a patient treated with human immunodeficiency virus protease inhibitorsYvonne Zysset Aschmann, Oliver Kummer, André Linka, et al.
Clinical Pharmacology and Therapeutics|December 18, 2020
Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2Fabio Bachmann, Urs Duthaler, Henriette E Meyer Zu Schwabedissen, et al.
Exploratory Research in Clinical and Social Pharmacy|May 27, 2026
Deprescribing of proton pump inhibitors in internal medicine in-patients: A retrospective observational studyChristina Kotoula, Leonie Daria Schreck, Arani Anandarathakrishnan, et al.
International Journal of Antimicrobial Agents|July 25, 2013
Activity of dalbavancin, alone and in combination with rifampicin, against meticillin-resistant Staphylococcus aureus in a foreign-body infection modelDaniela Baldoni, Ulrika Furustrand Tafin, Sandrine Aeppli, et al.
British Journal of Clinical Pharmacology|September 22, 2020
Effects of Hypericum perforatum (St John's wort) on the pharmacokinetics and pharmacodynamics of rivaroxaban in humansIrene Scholz, Evangelia Liakoni, Felix Hammann, et al.
Plos One|June 7, 2014
A study of the relationship between serum bile acids and propranolol pharmacokinetics and pharmacodynamics in patients with liver cirrhosis and in healthy controlsAnne B Taegtmeyer, Manuel Haschke, Lydia Tchambaz, et al.
Biochemical Pharmacology|January 18, 2019
Non-immunological toxicological mechanisms of metamizole-associated neutropenia in HL60 cellsDeborah Rudin, Angelo Lanzilotto, Fabio Bachmann, et al.
British Journal of Clinical Pharmacology|October 29, 2019
Pharmacokinetics and phenotyping properties of the Basel phenotyping cocktail combination capsule in healthy male adultsClaudia Suenderhauf, Benjamin Berger, Maxim Puchkov, et al.
Pageof 10